• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

MoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimab

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 04, 2021 at 10:42: AM
via There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA.

article source
 




Top Bottom
Back
Quote